Outcomes of Secondary Solid Tumor Malignancies Among Patients With Myeloma: A Population-Based Study

Cancer - United States
doi 10.1002/cncr.31853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase 1 Study of Cetuximab and Lapatinib in Patients With Advanced Solid Tumor Malignancies

Cancer
Cancer ResearchOncology
2015English

Clinical Outcomes of Bortezomib-Based Therapy in Taiwanese Patients With Multiple Myeloma: A Nationwide Population-Based Study and a Single-Institute Analysis

PLoS ONE
Multidisciplinary
2019English

Effect of Trabectedin on the QT Interval in Patients With Advanced Solid Tumor Malignancies

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients With Refractory Solid Malignancies: An Interventional Molecular Profiling Study

Oncologist
Cancer ResearchMedicineOncology
2018English

Risk of Stroke Among Patients With Cerebral Palsy: A Population-Based Cohort Study

Developmental Medicine and Child Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2016English

Tumor Characteristics, Treatments, and Survival Outcomes in Prostate Cancer Patients With a PSA Level < 4 Ng/Ml: A Population-Based Study

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Increased Risk of Malignancies in a Population-Based Study of 818 Soft-Tissue Sarcoma Patients

British Journal of Cancer
Cancer ResearchOncology
2006English

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients With Solid Malignancies

Clinical Cancer Research
Cancer ResearchOncology
2005English

Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited

Advances in Hematology
Hematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy